Status:
ACTIVE_NOT_RECRUITING
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Conditions:
Pulmonary Embolism
Venous Thromboembolism
Eligibility:
All Genders
Phase:
NA
Brief Summary
The researchers hypothesize that existing-prescription notifications directed to pharmacists are more likely to lead to a prescription change than existing-prescription notifications directed to presc...
Detailed Description
Please note that the 3rd and 4th outcome measures are conditional on the outcomes of the 1st and 2nd outcome measures respectively. Please note that enrollment of 300 will provide sufficient power to...
Eligibility Criteria
Inclusion
- Prescribers:
- Michigan Medicine provider with prescribing privileges
- Providers in ambulatory care settings
- Prescribe DOAC to patients 18 years and older
Exclusion
- Providers in inpatient settings
- Providers who are members of the study team
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2026
Estimated Enrollment :
306 Patients enrolled
Trial Details
Trial ID
NCT05351749
Start Date
August 1 2022
End Date
January 1 2026
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109